Dupilumab
DAIT CAUSE-01
Approved small_molecule active
Quick answer
Dupilumab for Asthma is a Approved program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 13 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Asthma
- Phase
- Approved
- Modality
- small_molecule
- Status
- active